Protagenic Total Assets vs Total Revenue Analysis

PTIXW Stock  USD 0.01  0.00  0.00%   
Protagenic Therapeutics financial indicator trend analysis is much more than just breaking down Protagenic Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Protagenic Therapeutics is a good investment. Please check the relationship between Protagenic Therapeutics Total Assets and its Total Revenue accounts. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Total Assets vs Total Revenue

Total Assets vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Protagenic Therapeutics Total Assets account and Total Revenue. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Protagenic Therapeutics' Total Assets and Total Revenue is 0.56. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Protagenic Therapeutics, assuming nothing else is changed. The correlation between historical values of Protagenic Therapeutics' Total Assets and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Protagenic Therapeutics are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Total Assets i.e., Protagenic Therapeutics' Total Assets and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.56
Relationship DirectionPositive 
Relationship StrengthWeak

Total Assets

Total assets refers to the total amount of Protagenic Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Protagenic Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Revenue

Total revenue comprises all receipts Protagenic Therapeutics generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.
Most indicators from Protagenic Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Protagenic Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
Selling General Administrative is likely to drop to about 1.1 M in 2024. Issuance Of Capital Stock is expected to grow at the current pace this year
 2022 2023 2024 (projected)
Interest Expense137.5K107.7K137.6K
Depreciation And Amortization30.028.2K26.8K

Protagenic Therapeutics fundamental ratios Correlations

0.020.54-0.150.630.58-0.020.190.080.570.570.72-0.48-0.480.71-0.20.570.68-0.12-0.170.880.12-0.24-0.240.81-0.27
0.02-0.090.88-0.70.360.76-0.8-0.080.370.36-0.31-0.41-0.41-0.260.870.37-0.160.790.89-0.180.940.830.83-0.18-0.35
0.54-0.09-0.330.530.64-0.210.420.20.640.640.12-0.58-0.580.7-0.40.640.21-0.39-0.340.32-0.03-0.44-0.450.08-0.36
-0.150.88-0.33-0.860.010.64-0.98-0.030.010.0-0.21-0.07-0.07-0.421.00.01-0.330.971.0-0.210.920.990.99-0.14-0.11
0.63-0.70.53-0.860.28-0.540.850.10.270.270.54-0.16-0.160.71-0.880.270.58-0.81-0.870.64-0.66-0.9-0.890.530.03
0.580.360.640.010.280.290.16-0.051.01.0-0.15-0.92-0.920.35-0.051.00.27-0.140.00.20.4-0.11-0.120.05-0.59
-0.020.76-0.210.64-0.540.29-0.55-0.690.310.31-0.31-0.42-0.42-0.310.650.310.00.540.66-0.230.680.610.61-0.06-0.43
0.19-0.80.42-0.980.850.16-0.55-0.030.160.170.11-0.13-0.130.37-0.980.160.34-1.0-0.980.15-0.84-0.99-0.990.09-0.07
0.08-0.080.2-0.030.1-0.05-0.69-0.03-0.07-0.090.170.220.220.21-0.06-0.07-0.140.05-0.040.23-0.02-0.03-0.03-0.060.39
0.570.370.640.010.271.00.310.16-0.071.0-0.16-0.94-0.940.33-0.041.00.27-0.140.00.180.4-0.1-0.110.05-0.62
0.570.360.640.00.271.00.310.17-0.091.0-0.16-0.95-0.950.31-0.051.00.28-0.150.00.170.39-0.11-0.120.04-0.64
0.72-0.310.12-0.210.54-0.15-0.310.110.17-0.16-0.160.210.220.59-0.22-0.160.56-0.05-0.220.91-0.21-0.22-0.210.940.21
-0.48-0.41-0.58-0.07-0.16-0.92-0.42-0.130.22-0.94-0.950.211.0-0.12-0.03-0.94-0.260.13-0.07-0.04-0.410.040.050.00.82
-0.48-0.41-0.58-0.07-0.16-0.92-0.42-0.130.22-0.94-0.950.221.0-0.12-0.03-0.94-0.260.13-0.07-0.04-0.410.040.050.00.82
0.71-0.260.7-0.420.710.35-0.310.370.210.330.310.59-0.12-0.12-0.460.320.37-0.31-0.430.74-0.2-0.48-0.490.520.14
-0.20.87-0.41.0-0.88-0.050.65-0.98-0.06-0.04-0.05-0.22-0.03-0.03-0.46-0.04-0.340.971.0-0.240.891.01.0-0.15-0.09
0.570.370.640.010.271.00.310.16-0.071.01.0-0.16-0.94-0.940.32-0.040.28-0.140.010.180.4-0.1-0.110.04-0.63
0.68-0.160.21-0.330.580.270.00.34-0.140.270.280.56-0.26-0.260.37-0.340.28-0.3-0.320.63-0.2-0.36-0.350.65-0.18
-0.120.79-0.390.97-0.81-0.140.54-1.00.05-0.14-0.15-0.050.130.13-0.310.97-0.14-0.30.97-0.070.840.980.98-0.020.09
-0.170.89-0.341.0-0.870.00.66-0.98-0.040.00.0-0.22-0.07-0.07-0.431.00.01-0.320.97-0.220.910.990.99-0.15-0.12
0.88-0.180.32-0.210.640.2-0.230.150.230.180.170.91-0.04-0.040.74-0.240.180.63-0.07-0.22-0.07-0.25-0.240.920.19
0.120.94-0.030.92-0.660.40.68-0.84-0.020.40.39-0.21-0.41-0.41-0.20.890.4-0.20.840.91-0.070.860.86-0.08-0.32
-0.240.83-0.440.99-0.9-0.110.61-0.99-0.03-0.1-0.11-0.220.040.04-0.481.0-0.1-0.360.980.99-0.250.861.0-0.16-0.04
-0.240.83-0.450.99-0.89-0.120.61-0.99-0.03-0.11-0.12-0.210.050.05-0.491.0-0.11-0.350.980.99-0.240.861.0-0.15-0.03
0.81-0.180.08-0.140.530.05-0.060.09-0.060.050.040.940.00.00.52-0.150.040.65-0.02-0.150.92-0.08-0.16-0.150.07
-0.27-0.35-0.36-0.110.03-0.59-0.43-0.070.39-0.62-0.640.210.820.820.14-0.09-0.63-0.180.09-0.120.19-0.32-0.04-0.030.07
Click cells to compare fundamentals

Protagenic Therapeutics Account Relationship Matchups

Protagenic Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets842.3K879.2K11.1M8.0M4.3M4.1M
Other Current Liab1.2M513.3K520.6K620.1K541.5K514.4K
Total Current Liabilities1.2M655.2K799.5K1.1M655.3K622.5K
Total Stockholder Equity(634.4K)(1.1M)9.9M6.9M3.7M6.1M
Property Plant And Equipment Net611.0296.00.01.8K123.3K117.2K
Net Debt(519.3K)702.7K(222.7K)129.0K(1.3M)(1.4M)
Retained Earnings(15.2M)(17.7M)(22.2M)(25.8M)(30.8M)(32.3M)
Cash798.6K671.1K541.2K215.2K1.3M2.0M
Non Current Assets Total611.0296.00.01.8K123.3K117.2K
Cash And Short Term Investments798.6K671.1K10.4M8.0M4.1M3.9M
Liabilities And Stockholders Equity842.3K879.2K11.1M8.0M4.3M4.1M
Non Current Liabilities Total52.4K279.4K1.4M318.4K1.0M0.0
Other Current Assets43.4K208.2K688.7K56.9K144.0K136.8K
Other Stockholder Equity14.7M16.7M32.4M33.4M34.6M41.2M
Total Liab1.5M2.0M1.1M1.1M655.3K622.5K
Total Current Assets842.0K879.2K11.1M8.0M4.2M7.5M
Accumulated Other Comprehensive Income(172.4K)(171.6K)(248.3K)(676.9K)(113.5K)(119.2K)
Accounts Payable36.2K141.9K279.0K155.5K113.8K108.1K
Net Invested Capital(355.0K)224.1K10.3M7.3M3.7M3.5M
Net Working Capital(355.3K)224.1K10.3M6.9M3.5M3.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Protagenic Stock Analysis

When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.